Eli Lilly | LLY - Ebit





Ebit Cambiamento Data
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 1.85B 684M 2026-03
ALKERMES USD -48.28M 37.33M 2026-03
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Baxter International USD 66M 280.2M 2026-03
Biogen USD 514.3M 502.8M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Drreddys Laboratories INR 16.37B 3.5B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
J&J USD 6.62B 1.51B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merck USD -1.88B 8.12B 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.18B 118M 2026-03
Novartis USD 4.06B 413M 2025-12
Novo Nordisk DKK 59.62B 27.24B 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 3.74B 2.23B 2025-09
United Therapeutics USD 325.8M 340.4M 2026-03
Zoetis USD 842M 7M 2026-03